Sponsored by:

AHA Scientific Sessions 2012

November 3-7, 2012 - Los Angeles

AHA Scientific Sessions 2012 - Los Angeles
Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Sunday November 11 2012

  • HDL Boosters Still Promising

    LOS ANGELES — Researchers continue the development of drugs designed to increase production of the so-called good cholesterol - high density lipoprotein cholesterol (HDL), despite bad news on that front at the annual scientific sessions of the American Heart Association.

Saturday November 10 2012

  • HF Tied to Higher Risk for Fatal Cancer

    LOS ANGELES — Patients who developed heart failure had a 68% increased risk of cancer, which was associated with a 56% increased risk of death, researchers reported here.

Friday November 9 2012

  • PPI-Aspirin Pill Eases GI Ulcers in Heart Patients

    LOS ANGELES — The incidence of gastric ulcers was reduced by more than half among individuals taking a combination tablet that added a proton pump inhibitor to aspirin for secondary prevention of heart disease, researchers reported here.

Thursday November 8 2012

  • Highlights from AHA 2012

  • Direct and Indirect MI Costs Staggering

    LOS ANGELES — Acute coronary syndrome often strikes in midlife, which is also mid-career, resulting in a loss of income for the patient and productivity for the employer, researchers said.

  • Is Looking Old a Mirror of the Heart?

    LOS ANGELES — Some of the hallmarks of "old age" — baldness or fat deposits on the eyelids — were tied to increased risks for heart disease, researchers showed here.

  • Risk Prediction for Adverse Events After Carotid Artery Stenting in Higher Surgical Risk Patients (Stroke)

Wednesday November 7 2012

Tuesday November 6 2012

Monday November 5 2012

Sunday November 4 2012

Saturday November 3 2012

  • Medicare Rule Irks Cardiologists

    LOS ANGELES — The Centers for Medicare and Medicaid Services served up something for cardiologists gathering here to digest: a decision on the 2013 physician fee schedule gives primary care clinicians a pay raise and gives recognition to clinicians who follow guidelines when treating cardiovascular disease.

  • No Excess Bleeding Risk with Dabigatran

    LOS ANGELES — Patients starting dabigatran (Pradaxa) did not have a higher risk of bleeding compared with new users of warfarin, according to a post-marketing data review by the FDA.

Friday November 2 2012

  • Bypass Vs. Stent Showdown Tops Full Agenda

    LOS ANGELES — A record 28 late-breaking clinical trials will be reported at the American Heart Association's Scientific Sessions, and the results are likely to have an immediate impact on clinical practice.